Invention Grant
- Patent Title: Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
-
Application No.: US15770255Application Date: 2016-10-27
-
Publication No.: US10344000B2Publication Date: 2019-07-09
- Inventor: Blair T. Lapointe , Peter H. Fuller , Hakan Gunaydin , Kun Liu , Danielle F. Molinari , Qinglin Pu , Mark E. Scott , B. Wesley Trotter , Hongjun Zhang
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agency: Dechert LLP
- International Application: PCT/US2016/059057 WO 20161027
- International Announcement: WO2017/075178 WO 20170504
- Main IPC: C07D231/56
- IPC: C07D231/56 ; C07D401/04 ; C07D491/052 ; C07D491/107 ; A61P19/02 ; A61P17/06 ; A61P29/00 ; A61P37/02 ; A61P11/06 ; C07D471/04
Abstract:
The present invention relates to compounds according to Formula I: and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Public/Granted literature
- US20180305320A1 SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF Public/Granted day:2018-10-25
Information query
